Poly ADP-ribose polymerase-1 and health

Experimental Biology and Medicine

Volumn 235, Issue 5, 2010, Pages 561-568

  Kirkland, James B ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Genomic stability; Inflammation; NAD; NF B; Niacin; Pellagra; Poly ADP ribose; Poly ADP ribose polymerase; Sirtuins

Indexed keywords

APOPTOSIS INDUCING FACTOR; CALCITRIOL; DOUBLE STRANDED DNA; FISETIN; FLAVONOID; GLYCOSYLTRANSFERASE INHIBITOR; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; NICOTINIC ACID; PROTEIN P53; QUERCETIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR AP 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D; ENZYME INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ACUTE STRESS; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL DAMAGE; CELL DEATH; CHROMATIN STRUCTURE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOUBLE STRANDED DNA BREAK; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOMIC INSTABILITY; GLOMERULONEPHRITIS; HEALTH STATUS; HEART MUSCLE ISCHEMIA; HEMORRHAGIC SHOCK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; NONHUMAN; OVARY CANCER; PROTEIN DNA BINDING; PROTEIN FUNCTION; REPERFUSION INJURY; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE INJURY; VITAMIN BLOOD LEVEL; ANIMAL; DRUG ANTAGONISM; HEALTH; METABOLISM; REVIEW;

ANIMALS; ENZYME INHIBITORS; HEALTH; HUMANS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 77952564025     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2010.009280     Document Type: Short Survey

References (64)

1. Kirkland JB. Niacin. In: Rucker R, Zempleni J, Suttie JW, McCormick DB, eds. Handbook of Vitamins. 4th edn. New York: Taylor and Francis, 2007:191
2. Laguna J, Carpenter KJ. Raw versus processed corn in niacin-deficient diets. J Nutr 1951;45:21-28
3. Schreiber V, Dantzer F, Ame JC, de Murcia G. Poly(ADP-ribose): novel functions for an old molecule. Nat Rev Mol Cell Biol 2006;7:517-528
4. Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. Front Biosci 2008;13:3046-3082
5. Menissier de Murcia J, Ricoul M, Tartier L, Niedergang C, Huber A, Dantzer F, Schreiber V, Ame JC, Dierich A, LeMeur M, Sabatier L, Chambon P, de Murcia G. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J 2003;22:2255-2263
6. Rouleau M, McDonald D, Gagne P, Ouellet ME, Droit A, Hunter JM, Dutertre S, Prigent C, Hendzel MJ, Poirier GG. PARP-3 associates with polycomb group bodies and with components of the DNA damage repair machinery. J Cell Biochem 2007;100:385-401
7. Berger NA, Sims JL, Catino DM, Berger SJ. Poly(ADP-ribose) polymerase mediates the suicide response to massive DNA damage: studies in normal and DNA-repair defective cells. Princess Takamatsu Symp 1983;13:219-226
8. Durkacz BW, Omidiji O, Gray DA, Shall S. (ADP-ribose)n participates in DNA excision repair. Nature 1980;283:593-596
9. Sims JL, Sikorski GW, Catino DM, Berger SJ, Berger NA. Poly(adenosinediphosphoribose) polymerase inhibitors stimulate unscheduled deoxyribonucleic acid synthesis in normal human lymphocytes. Biochemistry 1982;21:1813-1821
10. Yelamos J, Schreiber V, Dantzer F. Toward specific functions of poly(ADP-ribose) polymerase-2. Trends Mol Med 2008;14:169-178
11. Malanga M, Althaus FR. The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem Cell Biol 2005; 83:354-364
12. Rouleau M, Aubin RA, Poirier GG. Poly(ADP-ribosyl)ated chromatin domains: access granted. J Cell Sci 2004;117:815-825
13. Althaus FR, Hofferer L, Kleczkowska HE, Malanga M, Naegeli H, Panzeter P, Realini C. Histone shuttle driven by the automodification cycle of poly(ADP-ribose)polymerase. Environ Mol Mutagen 1993;22:278-282
14. Kedar PS, Stefanick DF, Horton JK, Wilson SH. Interaction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition. DNA Repair (Amst) 2008;7:1787-1798
15. Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 2004;25:259-264
16. Aguilar-Quesada R, Munoz-Gamez JA, Martin-Oliva D, Peralta-Leal A, Quiles-Perez R, Rodriguez-Vargas JM, Ruiz DA, Conde C, Ruiz-Extremera A, Oliver FJ. Modulation of transcription by PARP-1: consequences in carcinogenesis and inflammation. Curr Med Chem 2007;14:1179-1187
17. Tulin A, Spradling A. Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 2003;299:560-562
18. Schreiber V, Hunting D, Trucco C, Gowans B, Grunwald D, de Murcia G, de Murcia JM. A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage. Proc Natl Acad Sci USA 1995;92:4753-4757
19. Jacobson EL, Smith JY, Wielckens K, Hilz H, Jacobson MK. Cellular recovery of dividing and confluent C3H10T1/2 cells from N-methyl-N′-nitro- N-nitrosoguanidine in the presence of ADP-ribosylation inhibitors. Carcinogenesis 1985;6:715-718
20. Park SD, Kim CG, Kim MG. Inhibitors of poly(ADP-ribose) polymerase enhance DNA strand breaks, excision repair, and sister chromatid exchanges induced by alkylating agents. Environ Mutagen 1983;5:515-525
21. Wang ZQ, Auer B, Stingl L, Berghammer H, Haidacher D, Schweiger M, Wagner EF. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev 1995;9:509-520
22. Shall S, de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutat Res 2000;460:1-15
23. Schreiber V, Ame JC, Dolle P, Schultz I, Rinaldi B, Fraulob V, Menissier-de Murcia J, de Murcia G. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem 2002;277:23028-23036
24. Rawling JM, Jackson TM, Roebuck BD, Poirier GG, Kirkland JB. The effect of niacin deficiency on diethylnitrosamine-induced hepatic poly(ADP-ribose) levels and altered hepatic foci in the Fischer-344 rat. Nutr Cancer 1995;24:111-119
25. Rawling JM, ApSimon MM, Kirkland JB. Lung poly(ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat. Free Radic Biol Med 1996;20:865-871
26. Shah GM, Le Rhun Y, Sutarjono I, Kirkland JB. Niacin deficient SKH-1 mice are more susceptible to ultraviolet B radiation-induced skin carcinogenesis. Cancer Res 2002;131(Suppl. 11):3150S
27. Boyonoski AC, Spronck JC, Gallacher LM, Jacobs RM, Shah GM, Poirier GG, Kirkland JB. Niacin deficiency decreases bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. J Nutr 2002;132:108-114
28. Kostecki LM, Thomas M, Linford G, Lizotte M, Toxopeus L, Bartleman AP, Kirkland JB. Niacin deficiency delays DNA excision repair and increases spontaneous and nitrosourea-induced chromosomal instability in rat bone marrow. Mutat Res 2007;625:50-61
29. Spronck JC, Nickerson JL, Kirkland JB. Niacin deficiency alters p53 expression and impairs etoposide-induced cell cycle arrest and apoptosis in rat bone marrow cells. Nutr Cancer 2007;57:88-99
30. Bartleman AP, Jacobs R, Kirkland JB. Niacin supplementation decreases the incidence of alkylation-induced nonlymphocytic leukemia in Long-Evans rats. Nutr Cancer 2008;60:251-258
31. Shah GM, Le Rhun Y, Sutarjono I, Kirkland JB. Niacin deficient SKH-1 mice are more susceptible to ultraviolet B radiation-induced skin carcinogenesis. J Nutr 2001;131(Suppl. 11):p3150S
32. Gensler HL, Williams T, Huang AC, Jacobson EL. Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice. Nutr Cancer 1999;34:36-41
33. Benavente CA, Jacobson MK, Jacobson EL. NAD in skin: therapeutic approaches for niacin. Curr Pharm Des 2009;15:29-38
34. Halappanavar SS, Rhun YL, Mounir S, Martins LM, Huot J, Earnshaw WC, Shah GM. Survival and proliferation of cells expressing caspase-uncleavable poly(ADP-ribose) polymerase in response to death-inducing DNA damage by an alkylating agent. J Biol Chem 1999;274:37097-37104
35. Affar EB, Shah RG, Dallaire AK, Castonguay V, Shah GM. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage. Proc Natl Acad Sci USA 2002;99:245-250
36. Hassa PO, Hottiger MO. The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 2002;59:1534-1553
37. Peralta-Leal A, Rodriguez-Vargas JM, Aguilar-Quesada R, Rodriguez MI, Linares JL, de Almodovar MR, Oliver FJ. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases. Free Radic Biol Med 2009;47:13-26
38. Pacher P, Szabo C. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. Cardiovasc Drug Rev 2007;25:235-260
39. McCourtie AS, Farivar AS, Woolley SM, Merry HE, Wolf PS, Szabo C, Mulligan MS. Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation. Exp Mol Pathol 2008;84:141-144
40. Csiszar A, Wang M, Lakatta EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-kappaB. J Appl Physiol 2008;105:1333-1341
41. Jog NR, Dinnall JA, Gallucci S, Madaio MP, Caricchio R. Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation. J Immunol 2009;182:7297-7306
42. Garcia S, Bodano A, Pablos JL, Gomez-Reino JJ, Conde C. Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts. Ann Rheum Dis 2008;67:631-637
43. Jiang J, Zhang X, Yang H, Wang W. Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology. Methods Mol Biol 2009;471:305-333
44. Wang XG, Wang ZQ, Tong WM, Shen Y. PARP1 Val762Ala polymorphism reduces enzymatic activity. Biochem Biophys Res Commun 2007;354:122-126
45. Tezcan G, Gurel CB, Tutluoglu B, Onaran I, Kanigur-Sultuybek G. The Ala allele at Val762Ala polymorphism in poly(ADP-ribose) polymerase-1 (PARP-1) gene is associated with a decreased risk of asthma in a Turkish population. J Asthma 2009;46:371-374
46. Nikitin AG, Chudakova DA, Strokov IA, Bursa TR, Chistiakov DA, Nosikov VV. Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients. Diabetes Res Clin Pract 2008;79:446-452
47. Shestakov AE, Kamyshova ES, Petrosian EK, Kutyrina IM, Savost'ianov KV, Nosikov VV. Polymorphic markers Val762Ala and Leu54Phe of the ADPRT1 gene associated with chronic glomerulonephritis in Russian patients from the city of Moscow. Genetika 2007;43:261-264
48. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006;60:502-507
49. Sutherland JP, McKinley B, Eckel RH. The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004;2:82-104
50. Geraets L, Moonen HJ, Brauers K, Wouters EF, Bast A, Hageman GJ. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J Nutr 2007;137:2190-2195
51. Geraets L, Haegens A, Brauers K, Haydock JA, Vernooy JH, Wouters EF, Bast A, Hageman GJ. Inhibition of LPS-induced pulmonary inflammation by specific flavonoids. Biochem Biophys Res Commun 2009;382:598-603
52. Holick MF. Vitamin D: a D-Lightful health perspective. Nutr Rev 2008;66:S182-94
53. Mabley JG, Wallace R, Pacher P, Murphy K, Szabo C. Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D. Int J Mol Med 2007;19:947-952
54. Goldberg S, Visochek L, Giladi E, Gozes I, Cohen-Armon M. PolyADP-ribosylation is required for long-term memory formation in mammals. J Neurochem 2009;111:72-79
55. Strosznajder RP, Jesko H, Adamczyk A. Poly(ADP-ribose) polymerase-1 is a novel nuclear target for cholinergic receptor signaling in the hippocampus. J Physiol Pharmacol 2005;56(Suppl. 4):209-213
56. Krishnakumar R, Gamble MJ, Frizzell KM, Berrocal JG, Kininis M, Kraus WL. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 2008;319:819-821
57. Lonskaya I, Potaman VN, Shlyakhtenko LS, Oussatcheva EA, Lyubchenko YL, Soldatenkov VA. Regulation of poly(ADP-ribose) polymerase-1 by DNA structure-specific binding. J Biol Chem 2005;280:17076-17083
58. Drew Y, Plummer R. PARP inhibitors in cancer therapy: two modes of attack on the cancer cell widening the clinical applications. Drug Resist Updat 2009;12:153-156
59. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377
60. Suarez-Pinzon WL, Mabley JG, Power R, Szabo C, Rabinovitch A. Poly (ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes. Diabetes 2003;52:1683-1688
61. Yamagami T, Miwa A, Takasawa S, Yamamoto H, Okamoto H. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors. Cancer Res 1985;45:1845-1849
62. Gale EA, Bingley PJ, Emmett CL, Collier T. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004;363:925-931
63. Kirkland JB. Niacin status, NAD distribution and ADP-ribose metabolism. Curr Pharm Des 2009;15:3-11
64. Kirkland JB. Niacin status and treatment-related leukemogenesis. Mol Cancer Ther 2009;8:725-732